You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples.
Participants will be compensated $675 for completing all the visits.
To participate, please contact Tiffany at 205-934-0534 or email us at nauticalstudy@uabmc.edu.
Enjoy unique perspectives in this slideshow
Ford named first UAB SUCCESS Champion
A message of gratitude on Employee Appreciation Day
In this study, you will wear a blood pressure monitor for 24 hours and take home blood pressures with the same monitor for 7 days. At the end of the study we will collect laboratory samples and you will have an echocardiogram (ultrasound of your heart). You will not receive any medications or have to stop taking your medications to participate in the study.
You will not be eligible to participate if you have any heart rhythm abnormalities such as atrial fibrillation. You also will not be eligible if you are pregnant or have had any changes to your medications in the past 2 weeks, or you are a shift worker.
You will be compensated for your time.
For more information, call (205) 934-9281 or email julia01@uab.edu.
Share Your Perspective on PrEP
The purpose of this study is to get to know how you feel about seeing PrEP promotional messaging, such as advertisements, commercials, signs, or any other type of promotion by completing a 20-minute survey.
Compensation is $50.
If you are interested, please click the link below:
https://uabid.qualtrics.com/jfe/form/SV_a2GuOJU85wsk7EW
Hollis named chief financial officer at UAB
Participate in Type 2 Diabetes Research
The purpose of this NIH-funded trial is to examine the effects of three different diabetes treatments to determine if they improve night-time blood sugars.
This trial involves:
- A screening visit that includes a blood draw, urine test and physical exam
- Treatment with Metformin, Insulin Glargine (long-acting insulin) or the experimental drug Dorzagliatin which is FDA-approved for research, for up to 8 weeks
- 2-4 inpatient visits/ including two overnight stays at the Clinical Research Unit at 15th floor of Jefferson Tower.
- All visits to be completed within a three-month period.
Study-related tests and procedures are provided free of charge. Participants will be compensated up to $2,500 for study completion. All participants must be diagnosed with type 2 DM and not be on any type of insulin therapy.
Please contact Alaaeldin Hodhod at ahodhod@uabmc.edu or 205-996-9984 or Chanel Mason at 205-934-1921 or cnmason@uabmc.edu.
